| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/21/2009 | US20090131350 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 05/21/2009 | US20090131348 Micrornas differentially expressed in pancreatic diseases and uses thereof |
| 05/21/2009 | US20090131319 Protein of given amino acid sequence; heterologous polypeptide comprises Fc portion of antibody molecule; identifying agonists and antagonists; diagnosis and treatment of disease resulting from aberrant cell proliferation |
| 05/21/2009 | US20090131318 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/21/2009 | US20090131312 Non-natural chemokine receptor ligands and methods of use thereof |
| 05/21/2009 | US20090131310 Mucin3 egf-like domains |
| 05/21/2009 | US20090131309 Ica512 couples insulin secretion and gene expression in beta-cells |
| 05/21/2009 | US20090131308 Splice Variants of ErbB Ligands, Compositions and Uses Thereof |
| 05/21/2009 | US20090131275 Method For Preparing Genome Library, And Genome Library Prepared By The Method |
| 05/21/2009 | US20090131272 Transposition of maize ac/ds elements in vertebrates |
| 05/21/2009 | US20090131271 Method for delivering nucleic acid and device for delivering nucleic acid |
| 05/21/2009 | US20090131270 Methods for the detection of molecular interactions within cells |
| 05/21/2009 | US20090131266 Nucleic Acid-Like Proteins |
| 05/21/2009 | US20090131264 Method for selecting stable proteins in non-standard physicochemical conditions |
| 05/21/2009 | US20090130763 Method of Controlling Degradation of Protein by Tetracycline Antibiotic |
| 05/21/2009 | US20090130762 Activation of HCV-specific T cells |
| 05/21/2009 | US20090130761 Freeze-Dried Product for Introducing Nucleic Acid, Oligonucleic Acid or Derivative Thereof |
| 05/21/2009 | US20090130760 Method for the ubiquitination of common subunit of rna polymerases |
| 05/21/2009 | US20090130758 insecticidal activity of the protein against Lepidopteran pests (moths); biological pesticides |
| 05/21/2009 | US20090130752 Biodegradable poly(disulfide amine)s for gene delivery |
| 05/21/2009 | US20090130751 Reduction of off-target rna interference toxicity |
| 05/21/2009 | US20090130741 De novo synthesized plasmid, methods of making and use thereof |
| 05/21/2009 | US20090130727 Method of expressing long-chain prenyl diphosphate synthase |
| 05/21/2009 | US20090130725 Gene Sms 14 |
| 05/21/2009 | US20090130718 Gene site saturation mutagenesis |
| 05/21/2009 | US20090130716 Rationally designed antibodies |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/21/2009 | US20090130713 Trichoderma promoter |
| 05/21/2009 | US20090130711 Recombinant vector capable of increasing secretion of koji mold protease |
| 05/21/2009 | US20090130710 Enhancing vegetative protein production in transgenic plants using seed specific promoters |
| 05/21/2009 | US20090130709 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 05/21/2009 | US20090130705 NADP-Dependent Glucose Dehydrogenase From Gluconobacter Oxydans |
| 05/21/2009 | US20090130701 Novel sequence variants of multi-drug resistance genes, mdr1 and mrp1, and recombinant cells expressing mrp1 and mdr1 for assessment of drug penetration and disposition |
| 05/21/2009 | US20090130697 Biological systems input-output response system and plant sentinels |
| 05/21/2009 | US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 05/21/2009 | US20090130692 Use of microproteins as tryptase |
| 05/21/2009 | US20090130685 Plants With Altered Root Architecture, Related Constructs and Methods Involving Genes Encoding Leucine Rich Repeat Kinase (LLRK) Polypeptides and Homologs Thereof |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130676 Interaction trap systems for detecting protein interactions |
| 05/21/2009 | US20090130675 Genes Involved in the Biosynthesis of Thiocoraline and Heterologous Production of Same |
| 05/21/2009 | US20090130674 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 05/21/2009 | US20090130664 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa |
| 05/21/2009 | US20090130192 Class iii slrp agonists for the reduction of blood vessel formation |
| 05/21/2009 | US20090130145 Vaccine |
| 05/21/2009 | US20090130136 Chondroitin Sulphate a Binding Domains |
| 05/21/2009 | US20090130134 T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereof |
| 05/21/2009 | US20090130133 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 05/21/2009 | US20090130130 Mutant allergen(s) |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130123 Antibodies to west nile virus polypeptides |
| 05/21/2009 | US20090130120 monoclonal antibodies and fragments that bind to conserved epitopes of the G protein of respiratory syncytial virus(RSV) and which are minimally immunogenic when administered to humans, useful in treating RSV infections |
| 05/21/2009 | US20090130113 Compositions and methods for use for antibodies against sclerostin |
| 05/21/2009 | US20090130111 Method of Identifying Membrane Ig Specific Antibodies and Use Thereof for Targeting Immunoglobulin-Producing Precursor Cells |
| 05/21/2009 | US20090130110 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/21/2009 | US20090130105 Compositions that bind multiple epitopes of igf-1r |
| 05/21/2009 | US20090130103 Purification and protective efficacy of monodisperse and modified yersinia pestis capsular f1-v antigen fusion proteins for vaccination against plague |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130094 Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII |
| 05/21/2009 | US20090130069 Thymidine Kinase |
| 05/21/2009 | US20090130061 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/21/2009 | US20090130060 Modified Vitamin K Dependent Polypeptides |
| 05/21/2009 | US20090130034 Re-engineered uv damage endonuclease, compositions and methods |
| 05/20/2009 | EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof |
| 05/20/2009 | EP2060633A1 Mammalian artificial chromosomes |
| 05/20/2009 | EP2060632A1 Method of modifying a yeast cell for the production of ethanol |
| 05/20/2009 | EP2060631A2 Characterization of granulocytic ehrlichia and methods of use |
| 05/20/2009 | EP2060630A2 PCA3, PCA3 genes, and methods of use |
| 05/20/2009 | EP2060629A1 Method of separating small RNA molecules using kosmotropic salt |
| 05/20/2009 | EP2060628A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP2059610A1 Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer |
| 05/20/2009 | EP2059602A2 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors |
| 05/20/2009 | EP2059601A2 Methods for hybrid corn seed production and compositions produced therefrom |
| 05/20/2009 | EP2059600A2 Method for increasing resistance to pathogens in transgenic plants |
| 05/20/2009 | EP2059599A2 Enhanced expression method |
| 05/20/2009 | EP2059598A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 05/20/2009 | EP2059597A2 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| 05/20/2009 | EP2059596A2 Phased small rnas |
| 05/20/2009 | EP2059595A2 Compositions and methods for modulating mtor signaling |
| 05/20/2009 | EP2059594A1 Neukinase, a downstream protein of neuregulin |
| 05/20/2009 | EP2059593A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 05/20/2009 | EP2059592A1 Synthetic gene |
| 05/20/2009 | EP2059590A2 Methods for producing secreted polypeptides having biological activity |
| 05/20/2009 | EP2059587A2 Laccases for pulp bio-bleaching |
| 05/20/2009 | EP2059536A2 Optimized antibodies that target cd19 |
| 05/20/2009 | EP2059530A1 Method for the production of insulin-like growth factor-i |
| 05/20/2009 | EP2059263A1 Use of light sensitive genes |
| 05/20/2009 | EP2059261A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
| 05/20/2009 | EP1928227A4 Transgenic plants with enhanced agronomic traits |
| 05/20/2009 | EP1656458B1 Human autism susceptibility gene and uses thereof |
| 05/20/2009 | EP1592789B1 Administration of transposon-based vectors to reproductive organs |
| 05/20/2009 | EP1574521B1 Method of protecting of thiol groups in antibodies |
| 05/20/2009 | EP1478341A4 Efficient nucleic acid encapsulation into medium sized liposomes |
| 05/20/2009 | EP1341912B1 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 05/20/2009 | EP1330265B1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/20/2009 | EP1163260B1 Process for partitioning of proteins |
| 05/20/2009 | EP1158047B1 Microarrays having biological substance |
| 05/20/2009 | EP1078987B1 Method for examining central nervous system diseases and method for screening remedies |